Lapatinib Impurity I |
|
| Synonyms: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-((1-Oxyl-2,2,5,5-tetramethylpyrroline-3-yl)carbamido)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine; Demethylsulfonyl Lapatinib 1-Oxyl-2,2,5,5-tetramethyl-Æ3-pyrroline deriv; N-[3-Chloro-4-[(3-fluo | |
| Cat. No.: L12512 | CAS No.: N.A. |
| MDL.: | Formula: C37H37ClFN6O4 |
| F.W.684.18 | Purity: 99% |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | L12512 | CAS No.: | N.A. | |
| MDL: | Formula: | C37H37ClFN6O4 | ||
| F.W.: | 684.18 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Kim, T.E., et al.: Drugs, 6, 886 (2003), Wood, E.R., et al.: Cancer Res., 64, 6652 (2004), Spector, N.L., et al.: J. Clin. Oncol., 23, 2502 (2005), | |||
| Application: | N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-((1-Oxyl-2,2,5,5-tetramethylpyrroline-3-yl)carbamido)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine is an analog of Lapatinib Ditosylate which acts as a reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic. | |||
| Category: | Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||